From 25 February 2021, a new framework for regulating software as a medical device will commence. The Regulation of software based medical devices details these changes, and additionally the following guidance documents have also been published to assist users understand the various processes relevant to software as a medical device (SaMD):
The Therapeutic Goods Administration (TGA) is conducting an education campaign in order to help stakeholders further understand the new framework and meet the regulatory requirements, in efforts to minimise interruption to the supply of SaMD to Australians.
What the TGA would like to know:
The information gathered from this survey will help us develop material and deliver targeted information about the SaMD framework.
Share
Share on Twitter Share on Facebook